Global Montelukast API Market Research Report Forecast to 2023

Montelukast API Market Research Report - Global Forecast till 2023

Market Analysis
An orally offered leukotriene receptor antagonist that used widely for the treatment of asthma is Montelukast API. Respiratory problems related with the exercise-induced bronchospasm is prevented by the same. Also, the symptoms of hay fever and allergic rhinitis is relieved through this. The leukotrienes that are responsible for causing or worsening asthma and related allergies is blocked by this drug that works by reducing the inflammation in the airways.
The growing incidence of asthma is expected to lead the market graph. However, the availability of alternatives and unfavorable effects connected with montelukast are likely to detain the market graph.
The Global Montelukast API Market is anticipated to list a CAGR of 3.38% to reach USD 1,430,215.2 thousand by 2023. It is high in demand globally for asthma treatment. The growing rate of allergic rhinitis cases is boosting the growth of the segment expected to display the highest CAGR of 3.11% from 2018 to 2023.
North America considered for the largest market share of 39.25% in 2017, and the regional market is expected to list a CAGR of 3.12% during the forecast period. Asia-Pacific is expected to register the rapid CAGR. The China market is anticipated to list the maximum growth rate of 5.10% during the forecast period from 2018 to 2023. The Europe market is predictable to surpass USD 396,258 thousand by 2023. Growing incidence of asthma, COPD, and allergies are striving to the growth of the Montelukast API market in the region. The key contributor to the growth of the regional market is UK which is followed by France. Montelukast API Manufacturers, Pharmaceutical Companies, Contract Research Organizations, Contract Manufacturing Organizations are projected spectators.

Market segmentation
The Global Montelukast API Market is segmented in two parts, by Application and by region. By Application its sub-divided into Asthma, Allergic Rhinitis, Bronchospasm, Urticaria and Others. By Region it is divided into six countries i.e.; North America covering 2 countries US and Canada, Latin America, Europe while also covering Germany, Italy, Eastern Europe, Spain, UK, the Rest of Europe, Asia-Pacific covering countries like India, China, Japan, Rest of Asia-Pacific, Middle East and Africa.
Regional analysis
Geographically, the Global Montelukast API Market is intersected into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major players
Some major players in Montelukast API Market are: Sandoz International GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Dr. Reddys Laboratories Ltd (India), Morepen Laboratories Ltd (India), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd (Israel), Vintage Pharmaceuticals Inc (US), Hikma Pharmaceuticals PLC (UK), Glenmark (India), Merck Sharp & Dohme Corp (US), Sandoz International GmbH (Germany), Hetero (India) and Aurobindo Pharma (India).


1Executive Summary
1.1Market Attractiveness Analysis
1.1.1Global Montelukast API Market, By Application
1.1.2Global Montelukast API Market, By Region
2Market Introduction
2.1Definition
2.2Scope of the Study
2.3Market Structure
3Research Methodology
3.1Research Process
3.2Primary Research
3.3Secondary Research
3.4Market Size Estimation
3.5Forecast Model
3.6List of Assumptions
4Market Dynamics
4.1Introduction
4.2Drivers
4.2.1Increasing Incidence of Asthma
4.3Restraints
4.3.1Availability of Substitutes and Adverse Effects Associated with Montelukast
4.4Opportunities
4.4.1Opportunities Associated with the Technological Advancements
5Market Factor Analysis
5.1Supply Chain Analysis
5.1.1Research and Development
5.1.2Production
5.1.3Distribution & Sale
5.1.4Post-Sale Review
5.2Porters Five Forces Model
5.2.1Threat of New Entrants
5.2.2Intensity of Rivalry
5.2.3Threat of Substitutes
5.2.4Bargaining Power of Suppliers
5.2.5Bargaining Power of Buyers
5.3Regulatory Scenario
5.4Pipeline Analysis
5.4.1Introduction
5.4.2Montelukast 10 mg Tablet
5.4.3Montelukast Chewable 5 mg Tablets
5.4.4Montelukast buccal film
5.4.5Montelukast 10mg
5.5Pricing Evolution
5.6Patent Analysis
5.6.1Overview
6Global Montelukast API Market, by Application
6.1Introduction
6.2Asthma
6.3Allergic Rhinitis
6.4Bronchospasm
6.5Urticaria
6.6Others
7Global Montelukast API Market, by Region
7.1Introduction
7.2North America
7.2.1U.S.
7.2.2Canada
7.3Latin America
7.4Europe
7.4.1Spain
7.4.2France
7.4.3UK
7.4.4Germany
7.4.5Italy
7.4.6Eastern Europe
7.4.7Rest of Europe

7.5Asia-Pacific
7.5.1China
7.5.2India
7.5.3Japan
7.5.4Rest of Asia-Pacific
7.6The Middle East and Africa
7.6.1Middle East
7.6.2Africa
8Competitive Landscape
8.1Introduction
8.2Key Development Analysis
9Company Profiles
9.1Merck Sharp & Dohme Corp
9.1.1Financial Overview
9.1.2Products/Services Offered
9.1.3Key Developments
9.1.4SWOT Analysis
9.1.5Key Strategies
9.2Dr. Reddys Laboratories Ltd
9.2.1Financial Overview
9.2.2Products/Services Offered
9.2.3Key Developments
9.2.4SWOT Analysis
9.2.5Key Strategies
9.3Morepen Laboratories Ltd
9.3.1Financial Overview
9.3.2Products/Services Offered
9.3.3Key Developments
9.3.4SWOT Analysis
9.3.5Key Strategies
9.4Mylan N.V.
9.4.1Financial Overview
9.4.2Products/Services Offered
9.4.3Key Developments
9.4.4SWOT Analysis
9.4.5Key Strategies
9.5Teva Pharmaceutical Industries Ltd
9.5.1Financial Overview
9.5.2Products/Services Offered
9.5.3Key Developments
9.5.4SWOT Analysis
9.5.5Key Strategies
9.6Hikma Pharmaceuticals PLC
9.6.1Financial Overview
9.6.2Products/Services Offered
9.6.3Key Developments
9.6.4SWOT Analysis
9.6.5Key Strategies
9.7Glenmark
9.7.1Financial Overview
9.7.2Products/Services Offered
9.7.3Key Developments
9.7.4SWOT Analysis
9.7.5Key Strategies
9.8Sandoz International GmbH
9.8.1Financial Overview
9.8.2Products/Services Offered
9.8.3Key Developments
9.8.4SWOT Analysis
9.8.5Key Strategies
9.9Vintage Pharmaceuticals Inc
9.9.1Financial Overview
9.9.2Products/Services Offered
9.9.3Key Developments
9.9.4SWOT Analysis
9.9.5Key Strategies

9.1Hetero
9.10.1Financial Overview
9.10.2Products/Services Offered
9.10.3Key Developments
9.10.4SWOT Analysis
9.10.5Key Strategies
9.11Aurobindo Pharma
9.11.1Financial Overview
9.11.2Products/Services Offered
9.11.3Key Developments
9.11.4SWOT Analysis
9.11.5Key Strategies
10Conclusion
10.1Key Findings

List Of Tables



TABLE 1LIST OF ASSUMPTIONS
TABLE 2ATORVASTATIN API MARKET: PIPELINE ANALYSIS
TABLE 3PRICING EVOLUTION (20152018), BY REGION (USD PER KG)
TABLE 4PATENT ANALYSIS FOR THE GLOBAL DULOXETINE API MARKET
TABLE 5GLOBAL MONTELUKAST API, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 6GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 7GLOBAL MONTELUKAST API MARKET FOR ASTHMA, BY REGION, 20162023 (USD THOUSAND)
TABLE 8GLOBAL MONTELUKAST API MARKET FOR ASTHMA, BY REGION, 20162023 (TONS)
TABLE 9GLOBAL MONTELUKAST APIMARKET FOR ALLERGIC RHINITIS, BY REGION, 20162023 (USD THOUSAND)
TABLE 10GLOBAL MONTELUKAST API MARKET FOR ALLERGIC RHINITIS, BY REGION, 20162023 (TONS)
TABLE 11GLOBAL MONTELUKAST API MARKET FOR BRONCHOSPASM, BY REGION, 20162023 (USD THOUSAND)
TABLE 12GLOBAL MONTELUKAST APIMARKET FOR BRONCHOSPASM, BY REGION, 20162023 (TONS)
TABLE 13GLOBAL MONTELUKAST API MARKET FOR URTICARIA, BY REGION, 20162023 (USD THOUSAND)
TABLE 14GLOBAL MONTELUKAST APIMARKET FOR URTICARIA, BY REGION, 20162023 (TONS)
TABLE 15GLOBAL MONTELUKAST API MARKET FOR OTHERS, BY REGION, 20162023 (USD THOUSAND)
TABLE 16GLOBAL MONTELUKAST API MARKET FOR OTHERS, BY REGION, 20162023 (TONS)
TABLE 17GLOBAL MONTELUKAST API MARKET, BY REGION, 20162023 (USD THOUSAND)
TABLE 18GLOBAL MONTELUKAST API MARKET, BY REGION, 20162023 (TONS)
TABLE 19GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 20GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 21NORTH AMERICA MONTELUKAST API MARKET, BY COUNTRY, 20162023 (USD THOUSAND)
TABLE 22NORTH AMERICA MONTELUKAST APIMARKET, BY COUNTRY, 20162023 (TONS)
TABLE 23NORTH AMERICA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 24NORTH AMERICA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 25U.S. MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 26U.S. MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 27CANADA MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 28CANADA MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 29LATIN AMERICA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 30LATIN AMERICA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 31EUROPE MONTELUKAST API MARKET, BY COUNTRY, 20162023 (USD THOUSAND)
TABLE 32EUROPE MONTELUKAST API MARKET, BY COUNTRY, 20162023 (TONS)
TABLE 33EUROPE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 34EUROPE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 35SPAIN MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 36SPAIN MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 37FRANCE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 38FRANCE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 39UK MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 40UK MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 41GERMANY MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 42GERMANY MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 43ITALY MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 44ITALY MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 45EASTERN EUROPE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 46EASTERN EUROPE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 47REST OF EUROPE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 48REST OF EUROPE MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 49ASIA-PACIFIC MONTELUKAST API MARKET, BY COUNTRY, 20162023 (USD THOUSAND)
TABLE 50ASIA-PACIFIC MONTELUKAST API MARKET, BY COUNTRY, 20162023 (TONS)
TABLE 51ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 52ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 53CHINA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 54CHINA MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 55INDIA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 56INDIA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 57JAPAN MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 58JAPAN MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 59REST OF ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 60REST OF ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 61THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY REGION, 20162023 (USD THOUSAND)
TABLE 62THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY REGION, 20162023 (TONS)
TABLE 63THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 64THE MIDDLE EAST AND AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 65MIDDLE EAST MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 66MIDDLE EAST MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
TABLE 67AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (USD THOUSAND)
TABLE 68AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 20162023 (TONS)
TABLE 69KEY DEVELOPMENTS OVERVIEW

List Of Figures



FIGURE 1MARKET SYNOPSIS
FIGURE 2GLOBAL MONTELUKAST API MARKET ANALYSIS BY REGION
FIGURE 3GLOBAL MONTELUKAST API MARKET: MARKET STRUCTURE
FIGURE 4RESEARCH PROCESS FOR MRFR
FIGURE 5TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 6MARKET DYNAMICS OVERVIEW
FIGURE 7DRIVERS IMPACT ANALYSIS
FIGURE 8RESTRAINTS IMPACT ANALYSIS
FIGURE 9SUPPLY CHAIN: GLOBAL MONTELUKAST API MARKET
FIGURE 10PORTERS FIVE FORCES ANALYSIS OF THE GLOBAL MONTELUKAST API MARKET
FIGURE 11GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 20162023 (USD THOUSAND)
FIGURE 12GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 20162023 (TONS)
FIGURE 13GLOBAL MONTELUKAST API MARKET, BY REGION, 2017 (VALUE %)
FIGURE 14GLOBAL MONTELUKAST API MARKET BY REGION, 20162023 (TONS)

Global Thiotepa Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of

USD 4000 View Report

Global Electronic Dental Records Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of

USD 4000 View Report

Global Montelukast Intermediate Market Research Report Forecast to 2023

Global Montelukast Intermediate Market: Information by Application (Asthma, Allergic Rhinitis, Bronchospasm and Urticaria) - Forecast till 2023Market analysis The Global Montelukast Intermediate Market has been used to prevent wheezing, difficulty

USD 4450 View Report

Global Montelukast Methyl Ester (CAS 855473-51-7) Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Montelukast Methyl Ester is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available